Literature DB >> 8167177

Perioperative plasma erythropoietin levels in hip arthroplasty.

A Lorentz1, K U Eckardt, P M Osswald, C Kruse.   

Abstract

To examine the influence of intra- and postoperative blood loss and operative trauma on erythropoietin (EPO) production we studied patients undergoing endoprosthetic surgery of the hip. Immunoreactive plasma EPO was determined in ten patients (seven male, three female, aged 39-68 years), undergoing surgery for hip arthroplasty (n = 8) or revision hip arthroplasty (n = 2). EPO levels had already been determined during preoperative autologous deposit, thus allowing direct comparison between EPO response to blood loss alone and the response to blood loss and operative trauma. Perioperative blood loss amounted to 1720 (480-8100) ml (median, range). The hemoglobin concentration decreased from 12.4 (10.6-14.0) g/dl (median, range) before the operation to 10.0 (9.3-12.3) g/dl 2 h after the operation. Thereafter, the hemoglobin concentration increased slowly due to transfusion and erythropoiesis and was not significantly different (p < 0.05) from the preoperative value on the seventh postoperative day. The EPO concentration was preoperatively 26 (11-28) mU/ml and increased 2 h after the end of the operation, reaching a peak of 64 (45-104) mU/ml at 24 h. This peak was followed by a plateau at lower, but still elevated levels. The EPO concentration remained significantly elevated above the preoperative value on the seventh postoperative day. Plasma EPO concentrations showed an adequate response to postoperative anemia compared with the time course after autologous donation. In the early postoperative phase, they do not seem to be appreciably influenced by the neuroendocrine response to trauma, by mediators of inflammation, or by the postoperative catabolic state. The slightly elevated EPO concentration in the late postoperative phase indicates that factors other than anemia may contribute to EPO production at this time.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8167177     DOI: 10.1007/bf01727415

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  29 in total

Review 1.  Erythropoietin: structure, control of production, and function.

Authors:  W Jelkmann
Journal:  Physiol Rev       Date:  1992-04       Impact factor: 37.312

2.  Clinical evaluation of a fluorescence polarization immunoassay for quantifying C-reactive protein.

Authors:  J M González Buitrago; F Cava; A Gómez del Campo; J C Moyano; J A Navajo
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

3.  Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.

Authors:  L T Goodnough; S Rudnick; T H Price; S K Ballas; M L Collins; J P Crowley; M Kosmin; M S Kruskall; B A Lenes; J E Menitove
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

4.  Erythropoietin levels in patients depositing autologous blood in short intervals.

Authors:  A Lorentz; K U Eckardt; P M Osswald; J R Duchow
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

5.  Modulation of the production of erythropoietin by cytokines: in vitro studies and their clinical implications.

Authors:  W Jelkmann; M Wolff; J Fandrey
Journal:  Contrib Nephrol       Date:  1990       Impact factor: 1.580

6.  Erythropoietin deficiency after coronary artery bypass procedures.

Authors:  E A Levine; A L Rosen; L R Sehgal; S A Gould; J C Egrie; G S Moss
Journal:  Ann Thorac Surg       Date:  1991-05       Impact factor: 4.330

7.  Decline of erythropoietin formation at continuous hypoxia is not due to feedback inhibition.

Authors:  K U Eckardt; J Dittmer; R Neumann; C Bauer; A Kurtz
Journal:  Am J Physiol       Date:  1990-05

8.  Changes in metabolism and muscle composition associated with total hip replacement.

Authors:  C B Michelsen; J Askanazi; F E Gump; D H Elwyn; J M Kinney; F E Stinchfield
Journal:  J Trauma       Date:  1979-01

9.  An erythropoietic stimulating factor similar to erythropoietin released by macrophages after treatment with silica.

Authors:  I N Rich; W Heit; B Kubanek
Journal:  Blut       Date:  1980-05

10.  Erythropoietin secretion by isolated rat Kupffer cells.

Authors:  P Paul; S A Rothmann; J T McMahon; A S Gordon
Journal:  Exp Hematol       Date:  1984-12       Impact factor: 3.084

View more
  2 in total

Review 1.  Future Perspectives in Spinal Cord Repair: Brain as Saviour? TSCI with Concurrent TBI: Pathophysiological Interaction and Impact on MSC Treatment.

Authors:  Paul Köhli; Ellen Otto; Denise Jahn; Marie-Jacqueline Reisener; Jessika Appelt; Adibeh Rahmani; Nima Taheri; Johannes Keller; Matthias Pumberger; Serafeim Tsitsilonis
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

2.  Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate.

Authors:  L Bellamy; N Rosencher; Bi Eriksson
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.